Showing results (251-260 of 292) with videos related to
Sort By:
Pageof 30
Journal of Market Access & Health Policy|April 29, 2016
A review of the value of innovation in inhalers for COPD and asthmaJohann Christian Virchow, Cezmi A Akdis, Josep Darba, et al.Journal of Comparative Effectiveness Research|October 3, 2014
Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disordersMichael Schlander, Silvio Garattini, Søren Holm, et al.Plos One|January 27, 2026
The socioeconomic impact of inherited retinal dystrophies (IRDs) in Belgium: A cost-of-illness studyIne Vandersmissen, Janice Geers, Tom Denee, et al.Frontiers in Pharmacology|October 24, 2014
Different initiatives across Europe to enhance losartan utilization post generics: impact and implicationsJames C Moon, Brian Godman, Max Petzold, et al.BMC Medicine|June 15, 2014
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implicationsBrian Godman, Max Petzold, Kathleen Bennett, et al.BMC Health Services Research|June 20, 2023
Population health management in Belgium: a call-to-action and case studyBetty Steenkamer, Bert Vaes, Ernst Rietzschel, et al.Journal of Market Access & Health Policy|May 27, 2026
Between Rigor and Relevance: Why the EU HTA Guidelines on Indirect Comparisons Miss the MarkSamuel Aballéa, Mondher Toumi, Piotr Wojciechowski, et al.Journal of Market Access & Health Policy|August 16, 2023
Rule of Prevention: a potential framework to evaluate preventive interventions for rare diseasesEddie Gibson, Daniel A Ollendorf, Steven Simoens, et al.Therapeutic Innovation & Regulatory Science|October 31, 2024
Expert Consensus Recommendations on a Biosimilars Value Framework for the Gulf Cooperation Council CountriesKhalid A Alnaqbi, Ahmed Al-Jedai, Mohamed Farghaly, et al.Implementation Science : IS|March 13, 2016
Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trialPauline Anrys, Goedele Strauven, Benoit Boland, et al.Pageof 30